Showing all 5 results

  • Atenolol with Chlorthalidone tablets.
    Atenolol with Chlorthalidone tablets.
    In Stock

    Atenolol & Chlorthalidone Tablets

    Free

    Product Composition & Strength

    We supply this product as Film Coated Tablets. The combination is engineered to maintain therapeutic plasma levels over a 24-hour period, supporting once-daily dosing.

    Active IngredientStrength (Standard)Therapeutic Role
    Atenolol BP/USP50 mg / 100 mgCardioselective Beta-Blocker
    Chlorthalidone BP/USP12.5 mg / 25 mgLong-acting Diuretic
    ExcipientsQ.S.Magnesium Stearate / PovidoneStabilizing Core Matrix
  • Placeholder
    In Stock

    Telmisartan & Chlorthalidone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Bilayer or Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the micro-dosed diuretic.

    Active IngredientStrengthPrimary Clinical Function
    Telmisartan USP/Ph.Eur.40 mgStandard ARB maintenance dose for continuous 24-hour peripheral vasodilation and RAAS blockade.
    Chlorthalidone USP/Ph.Eur.6.25 mgHighly precise, long-acting thiazide-like diuresis optimized for maximum safety and efficacy.
    ExcipientsMeglumine / Sodium Hydroxide / Microcrystalline Cellulose / Sodium Starch GlycolateAlkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation and immediate dissolution)
  • Placeholder
    In Stock

    Telmisartan & Metoprolol Succinate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the kinetic polymer matrix.

    Active IngredientStrengthPrimary Clinical Function
    Telmisartan USP/Ph.Eur.50 mgCustom-titrated ARB dose for continuous 24-hour peripheral vasodilation and RAAS blockade.
    Metoprolol Succinate USP/Ph.Eur.40 mg (Enteric-Coated / ER)Cardioselective beta-1 blockade for continuous heart rate control and anti-anginal defense.
    ExcipientsMeglumine / Methacrylic Acid Copolymer (Enteric Coat) / Microcrystalline CelluloseAlkalizer for Telmisartan / Gastric-resistant polymer for Metoprolol (Engineered for strict kinetic segregation)
  • Placeholder
    In Stock

    Telmisartan & Metoprolol Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the kinetic polymer matrix.

    Active IngredientStrengthPrimary Clinical Function
    Telmisartan USP/Ph.Eur.40 mgStandard ARB maintenance dose for continuous 24-hour peripheral vasodilation.
    Metoprolol Succinate USP/Ph.Eur.25 mg (Extended-Release)Low-dose cardioselective beta-1 blockade for gentle heart rate control and initiation therapy.
    ExcipientsMeglumine / Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium HydroxideAlkalizer for Telmisartan / SR Polymer matrix for Metoprolol (Engineered for kinetic segregation)
  • Placeholder
    In Stock

    Telmisartan Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.

    Active IngredientStrengthPrimary Clinical Use
    Telmisartan USP/BP/Ph.Eur.20 mgInitiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients.
    Telmisartan USP/BP/Ph.Eur.40 mgStandard Global Dose: Once-daily maintenance therapy for essential hypertension.
    Telmisartan USP/BP/Ph.Eur.80 mgMaximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction.
    ExcipientsMeglumine / Sodium Hydroxide / Povidone / Magnesium StearateAlkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption)